We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a ...

Quantum-Si is a biotech star, with a 327% surge in stock price. Its proteomics platform and partnerships make it one to watch ...

H.C. Wainwright has recently initiated Quantum-Si Inc (QSI) stock to Buy rating, as announced on December 8, 2023, according to Finviz. Earlier, on September 25, 2023, Canaccord Genuity had reduced ...

Today, Benzinga's options scanner spotted 13 options trades for Quantum-Si. This isn't normal. The overall sentiment of these ...

On Tuesday, Quantum-Si Inc (QSI) stock saw a decline, ending the day at $2.7 which represents a decrease of $-0.63 or -18.92% from the prior close of $3.33. The stock opened at $3.2 and touched a low ...

The Protein Sequencing Companytm, announces the release of its latest preprint titled "Protein Barcoding and Next-Generation Protein Sequencing for Multiplexed Protein ...

Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today ...

As stipulated by Nasdaq Listing Rule 5450(a)(1), Quantum-Si was given a timeframe of 180 days to rectify the situation and meet the minimum bid price requirement. On December 5, 2024, the company ...

Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. (NASDAQ:PLTR), Ark 21Shares Bitcoin ...

It took less than a month for Branford-based biotech firm Quantum-Si Inc. to regain compliance for listing its stock on The Nasdaq Stock Market. In a filing with the Securities and Exchange ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...